Case presentation icu

Asking for Preferences

Reading File

Searching the Web

Surviving Sepsis Campaign 2024 guidelines management bundles

Finding Sources

Reading File

Finding Sources

Reading File

I now have excellent material from Harrison's and Goldman-Cecil. Let me compile the full teaching case presentation.

🏥 ICU Teaching Case Presentation: Septic Shock

PATIENT IDENTIFICATION


Name	Mr. A.K. (fictitious)
Age	67 years
Sex	Male
Weight	82 kg (IBW ~75 kg)
Admitted to	Medical ICU
Date	Day 1

CHIEF COMPLAINT

"Fever, confusion, and low blood pressure" for 12 hours.

HISTORY OF PRESENT ILLNESS

Mr. A.K. is a 67-year-old male with a history of type 2 diabetes, hypertension, and CKD stage 3 who presented to the emergency department with a 3-day history of dysuria and frequency, worsening to fever, chills, and altered mental status over the preceding 12 hours. His family reports he was increasingly confused and difficult to arouse at home. He has had no vomiting or diarrhea. No recent travel, sick contacts, or procedures.

On arrival to the ED:

T: 39.4°C, HR: 118 bpm, RR: 26/min, BP: 78/44 mmHg, SpO2: 91% on room air
Mental status: lethargic, GCS 11 (E3 V3 M5)

IV access was obtained, blood cultures x2 drawn, urinalysis sent, and 30 mL/kg (2,500 mL) of crystalloid initiated within 30 minutes. BP did not recover - patient was transferred to the MICU.

PAST MEDICAL HISTORY

Condition	Details
Type 2 Diabetes Mellitus	On metformin + sitagliptin; HbA1c 8.2% (3 months ago)
Hypertension	On amlodipine 10 mg
CKD Stage 3	Baseline Cr 1.6 mg/dL
BPH	On tamsulosin 0.4 mg

Surgical history: Appendectomy (age 22) Allergies: Penicillin (rash - no anaphylaxis documented) Social history: Retired schoolteacher, non-smoker, occasional alcohol Family history: Father died of MI; mother had DM

PHYSICAL EXAMINATION (on MICU arrival)

System	Findings
General	Lethargic, diaphoretic, flushed, ill-appearing
Vitals	T 39.6°C, HR 122, BP 82/50 (MAP 61), RR 28, SpO2 93% on 4L NC
HEENT	Dry mucous membranes; no meningismus
CVS	Tachycardia, regular rhythm; no murmurs; JVP low
Respiratory	Increased work of breathing; diffuse mild crackles bibasally
Abdomen	Soft, non-tender, no guarding
GU	Suprapubic tenderness; no CVA tenderness
Extremities	Warm, well-perfused peripherally (early distributive pattern)
Neuro	GCS 11, disoriented to time and place
Skin	No rash, no petechiae

INVESTIGATIONS

Labs on Admission

Test	Result	Reference
WBC	18,400/uL (86% neutrophils, 8% bands)	4,500-11,000
Hb	11.2 g/dL	13.5-17.5
Platelets	112,000/uL	150,000-400,000
Na	131 mEq/L	136-145
K	4.8 mEq/L	3.5-5.0
BUN	44 mg/dL	7-20
Creatinine	2.9 mg/dL	0.7-1.2 (baseline 1.6)
Glucose	322 mg/dL	70-99
Bilirubin (total)	1.9 mg/dL	0.2-1.2
ALT / AST	68 / 54 U/L	<40
Albumin	2.8 g/dL	3.5-5.0
Lactate	4.2 mmol/L	<2.0
Procalcitonin	18.4 ng/mL	<0.5
CRP	312 mg/L	<10
pH (ABG)	7.28	7.35-7.45
PaCO2	28 mmHg	35-45
PaO2	68 mmHg (on 4L NC)	80-100
HCO3	13 mEq/L	22-28
P/F ratio	~170	>300

Anion Gap: 131 - (101 + 13) = 17 (elevated; high-AG metabolic acidosis from lactate)

Urinalysis

WBC: >100/HPF, RBC: 5-10/HPF, nitrites: positive, leukocyte esterase: 3+, bacteria: many

Urine Culture: Pending

Blood Cultures x2: Pending

Chest X-ray

Mild bilateral lower lobe airspace opacities; no pneumothorax; no cardiomegaly

ECG

Sinus tachycardia at 120 bpm; no ischemic changes

Bedside Echocardiography (POCUS)

Hyperdynamic LV (EF ~65%), no significant pericardial effusion, IVC collapsible (volume responsive)

DIAGNOSIS

Primary Diagnosis:

Septic Shock (Sepsis-3 criteria)

Diagnostic criteria met:

Suspected infection (urosepsis)
Acute organ dysfunction: SOFA score 8 (see below)
Vasopressor requirement to maintain MAP ≥65 mmHg despite adequate fluid resuscitation
Serum lactate > 2 mmol/L (4.2 mmol/L) - not corrected by fluids

Sepsis-3 Definition (for teaching):

Sepsis = life-threatening organ dysfunction caused by dysregulated host response to infection. Operationalized by an acute change in total SOFA score ≥ 2.

Septic shock = subset of sepsis with vasopressor requirement to maintain MAP ≥ 65 mmHg AND serum lactate > 2 mmol/L despite adequate fluid resuscitation (hospital mortality >40%).

Harrison's Principles of Internal Medicine 22E, Chapter 315

SOFA Score Calculation

Organ	Parameter	Score
Respiratory (PaO2/FiO2 ~170)	170 = moderate impairment	2
Coagulation (Platelets 112k)	100-149	1
Liver (Bili 1.9)	1.2-1.9 = mild	1
Cardiovascular (MAP <65, on vasopressor)	Dopamine/NE use	2
CNS (GCS 11)	GCS 10-12	1
Renal (Cr 2.9)	2.0-3.4 mg/dL	1
TOTAL		8

(SOFA ≥ 2 = significant mortality risk; ≥ 11 = >50% mortality)

qSOFA (quick screening, not diagnostic):

Altered mentation: +1
RR ≥ 22: +1
SBP ≤ 100: +1
qSOFA = 3/3 (high risk, prompt ICU evaluation indicated)

DIFFERENTIAL DIAGNOSIS

Diagnosis	Against It
Cardiogenic shock	Hyperdynamic echo, low JVP, warm peripheries
Hypovolemic shock	Fever, leukocytosis, lactate very high; responds partially to fluids
Anaphylaxis	No urticaria, angioedema, or exposure history
Adrenal crisis	No hyperkalemia, eosinophilia; no prior steroid use
Acute pancreatitis	No abdominal pain, normal lipase
SIRS without infection	Urinalysis markedly abnormal; fever + leukocytosis with bands

(Differential based on Goldman-Cecil Medicine, Circulatory Therapy section)

MANAGEMENT PLAN

Immediate Priorities: "Hour-1 Bundle" (SSC 2021)

Element	Action in This Patient
1. Measure lactate	Done: 4.2 mmol/L - remeasure in 2h
2. Blood cultures x2	Done BEFORE antibiotics
3. Broad-spectrum antibiotics	Initiate within 1 hour (see below)
4. Crystalloid 30 mL/kg	In progress; 2.5L given
5. Vasopressor if MAP <65	Start norepinephrine

A. Hemodynamic Resuscitation

Fluids:

Complete 30 mL/kg isotonic crystalloid (balanced solution preferred: lactated Ringer's over NS to reduce hyperchloremic acidosis)
Reassess with POCUS after each 500 mL bolus (IVC collapsibility, lung B-lines)
Target: MAP ≥ 65 mmHg, UO ≥ 0.5 mL/kg/hr, lactate clearance ≥10% every 2h

"Early therapy is the cornerstone of emergency management, but such therapy need not achieve specific central hemodynamic or oxygen-delivery targets." (Goldman-Cecil Medicine, Treatment)

Vasopressors:

Norepinephrine (first-line) - start at 0.05-0.1 mcg/kg/min, titrate to MAP ≥ 65
If MAP remains low, add vasopressin 0.03 units/min as vasopressor-sparing agent
Avoid dopamine as first-line (higher mortality and arrhythmia risk vs. NE)
Consider dobutamine only if myocardial depression or low CO confirmed

"Norepinephrine is slightly, but not significantly, better than dopamine for reducing mortality when used as the first-line vasopressor for septic shock." (Goldman-Cecil Medicine)

Target MAP:

Standard: ≥ 65 mmHg (no benefit to higher targets in most patients)
Consider ≥ 70-80 mmHg in severe hypertension or known atherosclerosis

B. Antimicrobial Therapy

Source: Urinary tract (clinical + UA findings) Allergy: Penicillin (rash, not anaphylaxis) - proceed with caution; cross-reactivity low

Empiric Regimen	Rationale
Piperacillin-tazobactam 4.5g IV q8h (extended infusion)	Broad gram-negative coverage including Pseudomonas; risk of cross-reactivity with PCN rash is <2%
OR Ceftriaxone 2g IV q24h + metronidazole if PCN allergy concern	Avoids beta-lactam; narrower
Add vancomycin 25 mg/kg if MRSA risk (indwelling catheter, recent hospitalization)	Not indicated here initially

De-escalate within 48-72h based on culture sensitivities. Duration: 7-14 days for urosepsis with bacteremia (review per culture results).

Most common gram-negative organisms in US urosepsis: E. coli, Klebsiella spp., Pseudomonas aeruginosa. (Harrison's 22E, Chapter 315)

C. Respiratory Support

Currently SpO2 93% on 4L NC - inadequate
Escalate to high-flow nasal cannula (HFNC) at 40 L/min, FiO2 0.5
Target SpO2 ≥ 94%, PaO2 ≥ 70 mmHg
Monitor closely - P/F ratio 170 meets moderate ARDS criteria
Intubation criteria: RR >35, worsening hypoxemia (SpO2 <88% on HFNC), encephalopathy, hemodynamic collapse
If intubated: lung-protective ventilation - TV 6 mL/kg IBW (IBW = 75 kg → 450 mL), PEEP 8-12, FiO2 to target SpO2 88-95%

D. Source Control

Urine culture + sensitivity - expedite
Repeat urinalysis + urine Gram stain
Renal ultrasound - rule out obstructive uropathy (hydronephrosis, renal abscess) given BPH + urosepsis
If obstruction found - urgent urology consult for drainage
Remove any urinary catheter placed and replace with new sterile catheter; send urine from new catheter

E. Supportive Care

Intervention	Target/Details
Glycemic control	Glucose 140-180 mg/dL; insulin infusion protocol; hold metformin (AKI)
DVT prophylaxis	Enoxaparin 40 mg SC daily (renally dose-adjusted given Cr 2.9) OR UFH 5000u SC BID
Stress ulcer prophylaxis	Pantoprazole 40 mg IV daily (mechanically ventilated or coagulopathy)
Nutrition	Early enteral nutrition within 24-48h if hemodynamically stable; avoid TPN unless gut inaccessible
Steroids	Hydrocortisone 200 mg/day (continuous infusion or 50mg q6h) ONLY if refractory shock (NE >0.25 mcg/kg/min)
Sedation/Analgesia	If intubated: analgesia-first protocol; light sedation (RASS -1 to 0); daily awakening trials
Renal replacement	Not immediately - trend Cr, UO; CRRT if worsening AKI with volume overload, refractory acidosis, or K+ >6.5
Hold nephrotoxins	Metformin, NSAIDs, ACE inhibitors already held

MONITORING AND REASSESSMENT

Parameter	Frequency	Target
Vital signs, MAP	Continuous (arterial line)	MAP ≥ 65
Urine output	Hourly	≥ 0.5 mL/kg/hr
Lactate	Every 2h until normalized	Clearance ≥ 10% per 2h
Blood glucose	q1-2h while on insulin	140-180 mg/dL
Daily labs: CBC, BMP, LFTs, coags	q24h	Trend organ dysfunction
Blood cultures	24-48h if not clearing	Bacteremia clearance
Chest X-ray	Daily if intubated	ARDS progression
SOFA score	Daily	Track trajectory

DISCUSSION POINTS (for teaching)

1. Why Sepsis-3 matters: The 2016 Sepsis-3 definitions abandoned SIRS criteria (too sensitive, too non-specific) in favor of organ dysfunction (SOFA ≥2). This patient meets both sepsis AND septic shock (vasopressor + lactate >2 despite fluids). (Harrison's 22E, Chapter 315)

2. Lactate as a guide: Lactate of 4.2 mmol/L signals global tissue hypoperfusion. Serial lactate clearance (targeting >10% drop per 2 hours) is equivalent to and less invasive than ScvO2-guided therapy.

3. Why norepinephrine first? NE increases SVR without significant increase in heart rate. Dopamine's higher arrhythmia risk and no mortality benefit make it second-line. Vasopressin is added (not substituted) to reduce NE dose.

4. Antibiotic timing: Every hour of delay in antibiotic administration increases mortality by ~7%. Blood cultures must be obtained BEFORE antibiotics but must not delay antibiotic initiation beyond 1 hour.

5. The "ARDS complication" connection: P/F ratio 170 puts this patient in moderate ARDS territory. Sepsis is the most common cause of ARDS. Lung-protective ventilation (6 mL/kg IBW, plateau pressure <30 cmH2O) is mandatory if intubated.

6. Steroid controversy: Hydrocortisone is reserved for refractory septic shock (NE >0.25 mcg/kg/min). The ADRENAL trial (NEJM 2018) showed no 90-day mortality benefit but faster shock reversal and shorter ICU stay.

EXPECTED CLINICAL COURSE

Time	Expected if Responding
6h	Lactate trending down, MAP maintained on NE, mental status improving
24h	Culture results - de-escalate antibiotics
48-72h	Vasopressor weaning, fluid balance assessment (avoid fluid overload)
Day 3-5	Wean oxygen support; mobilize if stable
Day 7-10	Discharge from MICU to ward

PROGNOSIS

Hospital mortality for septic shock: ~30-40%
Key adverse prognostic features in this patient: Age >65, DM, CKD, AKI (Cr 2.9), lactate 4.2, P/F 170
SOFA 8 = estimated mortality ~20-30%; will reassess daily
Survivors are at risk for post-sepsis syndrome: cognitive impairment, fatigue, recurrent infections, muscle weakness for months

References: Harrison's Principles of Internal Medicine 22E (2025), Chapter 315; Goldman-Cecil Medicine, Circulatory Therapy; Surviving Sepsis Campaign 2021 Guidelines (SSC Hour-1 Bundle); WHO Sepsis Guidelines 2024

Explain this patient treatment very shortly

Mr. A.K. — Treatment Summary (Septic Shock from Urosepsis)

1. 🩸 Fluids

30 mL/kg crystalloid (2.5L given) to restore circulating volume
Use Lactated Ringer's (better than normal saline in sepsis)

2. 💉 Vasopressors

Norepinephrine (first-line) — to keep MAP ≥ 65 mmHg
Add vasopressin if NE dose gets high
Goal: adequate blood pressure + organ perfusion

3. 🦠 Antibiotics (within 1 hour)

Piperacillin-tazobactam (covers gram-negatives including Pseudomonas)
Blood cultures drawn before giving antibiotics
De-escalate in 48-72h once culture/sensitivity results return

4. 🫁 Oxygen

Escalate to high-flow nasal cannula
If worsening → intubate with lung-protective ventilation (6 mL/kg tidal volume)

5. 🔍 Source Control

Renal ultrasound to rule out obstruction (he has BPH)
Replace urinary catheter
Treat the underlying UTI as the primary source

6. 🛡️ Supportive Care

What	Why
Insulin infusion	Glucose 140-180 mg/dL
Hold metformin	AKI present
DVT prophylaxis	Immobile ICU patient
Stress ulcer cover	Pantoprazole
Steroids (hydrocortisone)	Only if shock remains refractory to NE

The Core Principle:

Kill the bug. Support the circulation. Protect the organs. Don't over-resuscitate.

Reassess lactate every 2 hours - if it's clearing (dropping >10%), the patient is responding.

This is a shared conversation. Sign in to Orris to start your own chat.